Citations

Clear

16280 citation(s) found for "Yu, David".

Counseling Readiness and Changes in Self-Evaluation during Intensive Group Psychotherapy
Osborne, David, Swenson, Wendell M.

Mayo Clinic

Psychological Reports | September 1, 2011 | Volume: 31 | Issue: 2 | Pages: 646-646

10.2466/pr0.1972.31.2.646 | PMID 5081359 Get It

Counseling Readiness and Changes in Perception of Spouse during Intensive Group Therapy
Osborne, David, Swenson, Wendell M., Hardman, John B.

Mayo Clinic

Psychological Reports | September 1, 2011 | Volume: 31 | Issue: 1 | Pages: 208-210

10.2466/pr0.1972.31.1.208 | PMID 5055896 Get It

This study attempted to relate scores on the counseling readiness scale of the Adjective Checklist to changes in perception of spouse during intensive group psychotherapy. The counseling readiness score was found to be unrelated to changes in the number of favorable adjectives used by S to describe the spouse or used by the spouse to describe S. A significant relationship was found between the counseling readiness score and changes in the number of unfavorable adjectives used to describe the spouse and used by the spouse to describe S. Possible reasons for this finding are discussed.
Endoscopic and surgical management of serrated colonic polyps
Léonard, Daniel , Dozois, Eric J. , Smyrk, Thomas C. , Suwanthanma, Weerapat , Baron, Todd H. , Cima, Robert R. , Larson, David W.

Mayo Clinic

British Journal of Surgery | September 1, 2011 | Volume: 98 | Issue: 12 | Pages: 1685-1694

10.1002/bjs.7654 | PMID 22034178 Get It

Abstract Background Serrated polyps are an inhomogeneous group of lesions that harbour precursors of colorectal cancer. Current research has been directed at further defining the histopathological characteristics of these lesions, but definitive treatment recommendations are unclear. The aim was to review the current literature regarding classification, molecular genetics and natural history of these lesions in order to propose a treatment algorithm for surgeons to consider. Methods The PubMed database was searched using the following search terms: serrated polyp, serrated adenoma, hyperplastic polyp, hyperplastic polyposis, adenoma, endoscopy, surgery, guidelines. Papers published between 1980 and 2010 were selected. Results Sixty papers met the selection criteria. Most authors agree that recommendations regarding endoscopic or surgical management should be based on the polyp's neoplastic potential. Polyps greater than 5 mm should be biopsied to determine their histology so that intervention can be directed accurately. Narrow-band imaging or chromoendoscopy may facilitate the detection and assessment of extent of lesions. Complete endoscopic removal of sessile serrated adenomas in the left or right colon is recommended. Follow-up colonoscopy is recommended in 2–6 months if endoscopic removal is incomplete. If the lesion cannot be entirely removed endoscopically, segmental colectomy is strongly recommended owing to the malignant potential of these polyps. Left-sided lesions are more likely to be pedunculated, making them more amenable to successful endoscopic removal. Conclusion Even though the neoplastic potential of certain subtypes of serrated polyp is heavily supported, further studies are needed to make definitive endoscopic and surgical recommendations.
Comparison of the WAIS and WAIS-R at Different Ages in a Clinical Population
Rogers, Dan L., Osborne, David

Mayo Clinic

Psychological Reports | September 1, 2011 | Volume: 54 | Issue: 3 | Pages: 951-956

10.2466/pr0.1984.54.3.951 | PMID 6473607 Get It

Performances on the Wechsler Adult Intelligence Scale (WAIS) and the WAIS-Revised (WAIS-R) were compared between groups at different ages. We studied 176 subjects (primarily outpatients) who were referred for assessment of cognitive function. Although all age groups tended to obtain lower scores on the WAIS-R, older subjects were penalized more on Performance and Full Scale IQs when the revised form was used. However, interactions suggest that differences in the scores on the WAIS and WAIS-R in a clinical population may reflect an interaction among age, presenting complaint, and other factors.
Cognitive Abilities and Lipomyelomeningocele
Friedrich, William N., Shurtleff, David, Shaffer, Joyce

Mayo Clinic

Psychological Reports | August 31, 2011 | Volume: 73 | Issue: 2 | Pages: 467-470

10.2466/pr0.1993.73.2.467 | PMID 8234598 Get It

Ten children with lipomyelomeningocele were evaluated with the WISC—R, the Wide Range Achievement Test—Revised, the Developmental Test of Visual-motor Integration, and the Child Behavior Checklist. These children were consecutive referrals to a birth defects clinic. Unlike their meningomyelocele counterparts, as a group these children appear to be average in their intellectual, academic, and behavioral characteristics. However, they exhibited low average perceptual motor skills, a feature more commonly seen in meningomyelocele.
Increasing treatment of ruptured cerebral aneurysms at high-volume centers in the United States
Leake, Caleb B., Brinjikji, Waleed , Kallmes, David F. , Cloft, Harry J.

Mayo Clinic

Journal of Neurosurgery | August 26, 2011 | Volume: 115 | Issue: 6 | Pages: 1179-1183

10.3171/2011.7.jns11590 | PMID 21961924 Get It

Object Evidence of better outcomes in patients with aneurysmal subarachnoid hemorrhage treated at higher-volume centers might be expected to result in more of these patients being referred to such centers. The authors evaluated the US National Inpatient Sample for the years 2001 to 2008 for trends in patient admissions for the treatment of ruptured aneurysms at high- and low-volume centers. Methods The authors determined the number of ruptured aneurysms treated with clipping or coiling annually at low-volume (≤ 20 patients/year) and high-volume (> 20 patients/year) centers and also counted the number of high- and low-volume centers performing each treatment. Hospitalizations for clipping or coiling ruptured aneurysms were identified by cross-matching International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes for the diagnosis of a ruptured aneurysm (ICD-9-CM 430) with procedure codes for clipping (ICD-9-CM 39.51) or coiling (ICD-9-CM 39.52, 39.79, or 39.72) cerebral aneurysms. Results In 2001, 31% (435 of 1392) of the patients who underwent clipping and 0% (0 of 122 patients) of those who underwent coiling did so at high-volume centers, whereas in 2008 these numbers increased to 62% (627 of 1016) and 68% (917 of 1351) of patients, respectively. For clipping procedures, the number of low-volume centers significantly declined from 177 in 2001 to 85 in 2008, whereas the number of high-volume centers remained constant at 13–15. For coiling procedures, the number of low-volume centers decreased from 62 in 2001 to 54 in 2008, whereas the number of high-volume centers substantially increased from 0 in 2001 to 16 in 2005 and remained constant thereafter. Conclusions The treatment of ruptured cerebral aneurysms increasingly occurs at high-volume centers in the US. This trend is favorable given that better outcomes are associated with the treatment of these lesions at high-volume centers.
Variants in Inflammation Genes Are Implicated in Risk of Lung Cancer in Never Smokers Exposed to Second-hand Smoke
Spitz, Margaret R., Gorlov, Ivan P. , Dong, Qiong, Etzel, Carol J. , Gorlova, Olga Y. , Chang, David W. , Zhang, Di , Cunningham, Julie M. , Yang, Ping , Wu, Xifeng , Amos, Christopher I. , Chen, Wei , Pu, Xia , Wang, Liang

Mayo Clinic

Cancer Discovery | August 26, 2011 | Volume: 1 | Issue: 5 | Pages: 420-429

10.1158/2159-8290.cd-11-0080 | PMID 22586632 Get It

AbstractLung cancer in lifetime never smokers is distinct from that in smokers, but the role of separate or overlapping carcinogenic pathways has not been explored. We therefore evaluated a comprehensive panel of 11,737 single-nucleotide polymorphisms (SNP) in inflammatory-pathway genes in a discovery phase (451 lung cancer cases, 508 controls from Texas). SNPs that were significant were evaluated in a second external population (303 cases, 311 controls from the Mayo Clinic). An intronic SNP in the ACVR1B gene, rs12809597, was replicated with significance and restricted to those reporting adult exposure to environmental tobacco smoke. Another promising candidate was an SNP in NR4A1, although the replication OR did not achieve statistical significance. ACVR1B belongs to the TGFR-β superfamily, contributing to resolution of inflammation and initiation of airway remodeling. An inflammatory microenvironment (second-hand smoking, asthma, or hay fever) is necessary for risk from these gene variants to be expressed. These findings require further replication, followed by targeted resequencing, and functional validation.Significance: Beyond passive smoking and family history of lung cancer, little is known about the etiology of lung cancer in lifetime never smokers that accounts for about 15% of all lung cancers in the United States. Our two-stage candidate pathway approach examined a targeted panel of inflammation genes and has identified novel structural variants that appear to contribute to risk in patients who report prior exposure to sidestream smoking. Cancer Discovery; 1(5): 420–9. ©2011 AACR.This article is highlighted in the In This Issue feature, p. 367
Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults
Kantarci, Kejal , Lowe, Val J. , Przybelski, Scott A. , Senjem, Matthew L. , Weigand, Stephen D. , Ivnik, Robert J., Roberts, Rosebud O., Geda, Yonas E. , Petersen, R. C., Jack, Clifford R. , Boeve, Bradley F. , Knopman, David S. , Jack, Clifford R , Senjem, Matthew L , Kantarci, Kejal , Geda, Yonas E

Mayo Clinic

Neurology | August 25, 2011 | Volume: 77 | Issue: 10 | Pages: 951-958

10.1212/wnl.0b013e31822dc7e1 | PMID 21865577 Get It

Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone
Kumar, Shaji , Uno, Hajime , Jacobus, Susanna , Wier, Scott A. Van, Ahmann, Greg, Henderson, Kimberly J., Haug, Jessica, Greipp, Philip R., Fonseca, Rafaël , Rajkumar, S. Vincent , Callander, Natalie S. , Siegel, David S. , Rajkumar, S Vincent , Uno, Hajime , Fonseca, Rafael

Mayo Clinic

Blood | August 23, 2011 | Volume: 118 | Issue: 16 | Pages: 4359-4362

10.1182/blood-2011-03-342089 | PMID 21860025 Get It

Abstract Detection of specific chromosomal abnormalities by FISH and metaphase cytogenetics allows risk stratification in multiple myeloma; however, gene expression profiling (GEP) based signatures may enable more specific risk categorization. We examined the utility of 2 GEP-based risk stratification systems among patients undergoing initial therapy with lenalidomide in the context of a phase 3 trial. Among 45 patients studied at baseline, 7 (16%) and 10 (22%), respectively, were high-risk using the GEP70 and GEP15 signatures. The median overall survival for the GEP70 high-risk group was 19 months versus not reached for the rest (hazard ratio = 14.1). Although the medians were not reached, the GEP15 also predicted a poor outcome among the high-risk patients. The C-statistic for the GEP70, GEP15, and FISH based risk stratification systems was 0.74, 0.7, and 0.7, respectively. Here we demonstrate the prognostic value for GEP risk stratification in a group of patients primarily treated with novel agents. This trial was registered at www.clinicaltrials.gov as #NCT00098475.